Valuation: UCB

Market Cap 44.87B 51.32B 41.39B 38.05B 72.09B 4,938B 73.32B 494B 194B 2,414B 193B 188B 8,319B P/E 2026 *
25.3x
P/E 2027 * 20.1x
Enterprise Value 44.6B 51.01B 41.14B 37.82B 71.66B 4,908B 72.88B 491B 193B 2,399B 192B 187B 8,269B EV / Sales 2026 *
5.22x
EV / Sales 2027 * 4.42x
Free-Float
61.59%
Yield 2026 *
0.62%
Yield 2027 * 0.64%
1 day-0.59%
1 week-6.28%
Current month-10.57%
1 month-6.28%
3 months-9.43%
6 months-11.78%
Current year-1.80%
1 week 230.7
Extreme 230.7
253.4
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 169.35
Extreme 169.35
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
Jan. 14Fiscal year

Executive/Senior Manager

3,000 0.0015%
Jan. 14Buy

Director

500 0.0003%
Jan. 14Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-6.28%+38.11%+192.29% 51.32B
+1.27%+0.24%+21.26%-7.53% 67.6B
+1.10%+38.30%+38.30%+38.30% 42.97B
+0.16%-2.85%-50.72%-52.88% 40.81B
+2.76%-1.56%+54.70%-29.29% 29.12B
+1.25%-7.48%+116.21%-43.73% 27.09B
+0.18%-1.85%+68.63%+86.35% 22.99B
-2.94%+9.09%+9.28%+199.05% 21.55B
+3.84%-1.00%+67.49%+130.32% 16.38B
-1.70%+5.53%+76.00%+353.68% 16.2B
Average +0.47%+0.00%+43.93%+86.66% 33.6B
Weighted average by Cap. +0.55%-0.47%+35.19%+62.35%

Financials

2026 *2027 *
Net sales 8.54B 9.77B 7.88B 7.24B 13.72B 940B 13.95B 94.04B 36.9B 459B 36.68B 35.87B 1,583B 9.64B 11.02B 8.89B 8.17B 15.48B 1,061B 15.75B 106B 41.64B 518B 41.39B 40.49B 1,787B
Net income 1.77B 2.02B 1.63B 1.5B 2.84B 194B 2.88B 19.44B 7.63B 94.96B 7.58B 7.42B 327B 2.27B 2.6B 2.1B 1.93B 3.65B 250B 3.72B 25.04B 9.82B 122B 9.77B 9.55B 422B
Net Debt -271M -310M -250M -230M -436M -29.86B -443M -2.99B -1.17B -14.59B -1.17B -1.14B -50.3B -2.31B -2.65B -2.13B -1.96B -3.72B -255B -3.78B -25.47B -10B -124B -9.94B -9.72B -429B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-16 234.30 -0.59% 11,854
26-07-15 €235.70 +1.38% 167,608
26-07-14 €232.50 -1.32% 152,960
26-07-13 €235.60 -0.63% 192,311
26-07-10 €237.10 -5.16% 222,991
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
235.70EUR
Average target price
287.95EUR
Spread / Average Target
+22.17%

Quarterly revenue - Rate of surprise